AVEO Pharmaceuticals, Inc. (AVEO)

[Biotech Pharmer]

Accumulation is underway in a big way and it's not retail. And FCY, your assessment of management is a bit harsh, IMO. This is SOP for development stage pharmas and biotechs. Once the anticipated 1H2017 news begins, this public offering will be a speed bump in the rear view mirror. This company's pipeline has way too much going for it at this point in time to dismiss. A 180 day extension from NASD is probable at 4/10.